Non-benzodiazepine sedative-hypnotic (Z-drug)

Sonata (zaleplon) Withdrawal

Sonata (zaleplon) has the shortest half-life of the Z-drugs, which makes it less likely to produce next-day residual effects but more likely to produce middle-of-night awakening. Discontinuation is generally mild because chronic dependence is less common with such a short-acting agent.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~1 hour (the shortest of the Z-drugs).

Withdrawal timeline

Onset— 6-12 hours after stopping

Any rebound emerges quickly given the very short half-life.

Peak— Days 1-3

Mild rebound insomnia in the first few days.

Resolution— 1-2 weeks

Resolves over 1-2 weeks for most users.

Common symptoms

  • Mild rebound insomnia
  • Anxiety

Less common

  • Vivid dreams

Tapering guidance

  • Most patients can stop Sonata directly without a formal taper given the short half-life and lower dependence potential.
  • Plan sleep-support strategies.

Where ketamine therapy fits

Same considerations as other Z-drugs. The very short half-life means Sonata clears quickly, which makes timing around ketamine sessions easier than with longer-acting sleep medications.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

How long does Sonata withdrawal last?

Mild rebound insomnia in the first few days, full resolution in 1-2 weeks. Lower dependence potential than longer-acting Z-drugs.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.